• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOTRONIK AG, BUELACH, SWITZERLAND ORSIRO (US) 3.0/40; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOTRONIK AG, BUELACH, SWITZERLAND ORSIRO (US) 3.0/40; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number 404675
Medical Device Problem Code Device Dislodged or Dislocated (2923)
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Date of Event 09/19/2019
Type of Reportable Event Malfunction
Event or Problem Description
An orsiro drug-eluting stent was chosen to treat a pre-dilated lesion in the mid rca.The lesion could not be crossed and the device was withdrawn.During withdrawal the stent dislodged from balloon.The stent was adapted to the vessel wall with another balloon.
 
Additional Manufacturer Narrative
The complaint instrument was not returned for a technical investigation.Therefore, no technical investigation on the subject could be performed.The corresponding production documentation was reviewed to establish whether a deviation from the manufacturing process could be the cause for this event.In addition, the angiographic material provided was reviewed.Review of the production documentation for the product detailed above verified that the instrument was manufactured according to specifications and fulfilled all the requirements of in-process and final inspection.During final inspection, every stent system undergoes visual inspection to ensure correct stent embedding and homogeneous crimping of the stent.Further, the stent outer diameter is verified to 100 percent and the stent retention force of a defined amount of samples is tested from every lot.Review of the angiographic material did not lead to any further information regarding the nature of the complaint.The actual complaint event is not visible in the provided angiographic material.Based on the conducted investigations of the device being subject to this complaint, no material or manufacturing related root cause could be determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ORSIRO (US) 3.0/40
Common Device Name
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BIOTRONIK AG, BUELACH, SWITZERLAND
ackerstrasse 6
buelach CH-81 80
CH  CH-8180
MDR Report Key9167826
Report Number1028232-2019-04357
Device Sequence Number2614658
Product Code NIQ
UDI-Device Identifier07640130439443
UDI-Public07640130439443
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
P170030
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2019
Reporter Type Manufacturer
Report Source company representative,user f
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 09/20/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date06/24/2021
Device Model Number404675
Device Catalogue NumberSEE MODEL NO.
Device Lot Number06191827
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 09/20/2019
Supplement Date Received by Manufacturer11/14/2019
Initial Report FDA Received Date10/08/2019
Supplement Report FDA Received Date11/14/2019
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization;
-
-